Scientific basis for the efficacy of combined use of antirheumatic drugs against bone destruction in rheumatoid arthritis

Author： Suematsu Ayako Tajiri Yasuhito Nakashima Tomoki Taka Junko Ochi Sae Oda Hiromi Nakamura Kozo Tanaka Sakae Takayanagi Hiroshi

Publisher： Springer Publishing Company

ISSN： 1439-7595

Source： Modern Rheumatology, Vol.17, Iss.1, 2007-02, pp. : 17-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Molecular mechanism of bone destruction in rheumatoid arthritis

By Miyazaki Tsuyoshi Yamamoto Seizo Tanaka Sakae

Future Rheumatology, Vol. 2, Iss. 1, 2007-02 ,pp. : 61-72

Future Medicine

Access to resources Recommend Favorite

Use of Liposomal Drugs in the Treatment of Rheumatoid Arthritis

Current Rheumatology Reviews, Vol. 4, Iss. 1, 2008-02 ,pp. : 63-70

Bentham Science Publishers

Access to resources Recommend Favorite

Leflunomide discontinuation in rheumatoid arthritis and influence of associated disease-modifying anti-rheumatic drugs: a survival analysis

By Rodriguez-Rodriguez L Jover-Jover JA Fontsere O Peña-Blanco RC León L Fernández-Gutierrez B Abásolo L

Scandinavian Journal of Rheumatology, Vol. 42, Iss. 6, 2013-11 ,pp. : 433-436

Informa Healthcare

Access to resources Recommend Favorite

Can disease-modifying anti-rheumatic drugs be discontinued in long-standing rheumatoid arthritis? A 15-year follow-up

By Tiippana-Kinnunen T Paimela L Kautiainen H Laasonen L Leirisalo-Repo M

Scandinavian Journal of Rheumatology, Vol. 39, Iss. 1, 2010-05 ,pp. : 12-18

Informa Healthcare

Access to resources Recommend Favorite

Prospective study of HBV reactivation risk in rheumatoid arthritis patients who received conventional disease-modifying antirheumatic drugs

By Tan Jing

Clinical Rheumatology, Vol. 31, Iss. 8, 2012-08 ,pp. : 1169-1175

Springer Publishing Company

Access to resources Recommend Favorite